Sponsor:
Northwestern University
Code:
NCT06062498
Conditions
Estrogen-receptor-positive Breast Cancer
HER2/Neu-Negative Breast Cancer
Advanced Breast Cancerv
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
elacestrant, palbociclib, abemaciclib, ribociclib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-02. This information was provided to ClinicalTrials.gov by Northwestern University on 2025-10-20.